Department of Health
and Human Services (HHS)
and Human Services (HHS)
May 29, 2020
RFA-CA-19-049 Revision Applications for Mechanisms of Cancer Drug Resistance (R01 Clinical Trial Not Allowed)
RFA-CA-19-050 Revision Applications for Mechanisms of Cancer Drug Resistance (U01 Clinical Trial Not Allowed)
RFA-CA-19-051 Revision Applications for Mechanisms of Cancer Drug Resistance (U54 Clinical Trial Not Allowed)
RFA-CA-19-052 Revision Applications for Mechanisms of Cancer Drug Resistance (P01 Clinical Trial Not Allowed)
RFA-CA-19-053 Revision Applications for Mechanisms of Cancer Drug Resistance (P50 Clinical Trial Not Allowed)
National Cancer Institute (NCI)
NCI will accommodate the late submission of applications submitted to NCI-specific Requests for Applications (RFAs) with an Application Due Date of June 24, 2020 (see list below). Institutions do not need to request advance permission. Providing a cover letter that references this Notice is helpful but not required. Applications will not be accepted beyond 5:00 PM local time on the “Late Applications Accepted Through” date indicated below.
| Title | FOA Number | Application Due Date | Late Applications Accepted Through |
| Revision Applications for Mechanisms of Drug Resistance (R01 Clinical Trials Not Allowed) | RFA-CA-19-049 | June 24, 2020 | July 8, 2020 |
| Revision Applications for Mechanisms of Drug Resistance (U01 Clinical Trials Not Allowed) | RFA-CA-19-050 | June 24, 2020 | July 8, 2020 |
| Revision Applications for Mechanisms of Drug Resistance (U54 Clinical Trials Not Allowed) | RFA-CA-19-051 | June 24, 2020 | July 8, 2020 |
| Revision Applications for Mechanisms of Drug Resistance (P01 Clinical Trials Not Allowed) | RFA-CA-19-052 | June 24, 2020 | July 8, 2020 |
| Revision Applications for Mechanisms of Drug Resistance (P50 Clinical Trials Not Allowed) | RFA-CA-19-053 | June 24, 2020 | July 8, 2020 |
Jeffrey Hildesheim, Ph.D.
National Cancer Institute (NCI)
Telephone: 301-325-3167
Email: Hildesheimj@mail.nih.gov